To taper off GLP-1 medication, step the dose down gradually with the prescribing doctor, never on your own. About two-thirds of the lost weight returned within a year when the STEP 1 extension stopped semaglutide overnight (Wilding 2022), and in STEP 4 weight rose 6.9% on average in the 48 weeks after a switch to placebo (Rubino 2021); individual results vary. The GetLean GLP-1 Taper Plan plans the taper from your first consultation, toward your lowest effective dose and, where clinically appropriate, off the medication.
In SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide after 60 weeks were still 16.6% below their starting weight a year later (Horn 2026); individual results vary. At GetLean you don't stop overnight: Dr Quek plans your taper from the first consultation, where clinically appropriate, and steps the dose down at the monthly reviews. The GetLean GLP-1 Taper Plan works towards the lowest effective dose and, where clinically appropriate, off the medication.
In Singapore, tirzepatide is registered as Mounjaro, and semaglutide injection as Wegovy for weight management and as Ozempic for type 2 diabetes. The figures in this article are given by molecule, as the trials and product labels report them.
Lowest effective dose: the smallest dose that still achieves the clinical goal, rather than the highest dose a person can tolerate. A principle for how a medication is prescribed, not a number.
What the withdrawal trials actually tested
All of them tested the same thing: taking the medication away.
In STEP 4, participants completed a 20-week run-in on semaglutide and were then randomised either to continue or to switch to placebo. SURMOUNT-4 used the same design with tirzepatide after a 36-week lead-in (Rubino 2021, Aronne 2024). The STEP 1 extension followed people after both the medication and the trial's lifestyle programme stopped at week 68: about two-thirds of the lost weight returned within a year, and the group was still 5.6% below its starting weight (Wilding 2022).
The three withdrawal trials this article cites, and how each one took the medication away.
| Trial | Medicine | Treatment before the stop | How the medication was taken away | Source |
|---|---|---|---|---|
| STEP 4 | semaglutide | 20-week run-in | Randomised to continue or to switch to placebo | Rubino 2021 |
| SURMOUNT-4 | tirzepatide | 36-week lead-in | The same design: continue or switch to placebo | Aronne 2024 |
| STEP 1 extension | semaglutide | 68 weeks | The medication and the trial's lifestyle programme both stopped at week 68 | Wilding 2022 |
So the withdrawal trials describe one way of coming off: the medication taken away, by stopping it or by switching to placebo. A planned taper is a different route.
Why taper rather than stop?
Because the withdrawal trials took the medication away, by stopping it or by switching people to placebo, and in the STEP 1 extension, which stopped it overnight, about two-thirds of the lost weight returned within a year (Wilding 2022). At GetLean the dose comes down gradually under Dr Quek, so appetite adjusts step by step while the habits take over.
The medication quiets appetite while it is taken. Stopped overnight, that effect fades over the following weeks, and the habits in place by then are what is left. That is biology, not a lack of willpower. A step-down brings the dose down in stages instead, with the eating pattern and the training habit built during treatment already in place.
For the weeks after the last dose of each medicine, see coming off Mounjaro and coming off Wegovy; for stepping down rather than stopping, see the maintenance dose.
How the GetLean GLP-1 Taper Plan brings the dose down
At GetLean, we favour a gradual reduction under a doctor's guidance rather than a cliff-edge stop, which allows your appetite to adjust incrementally. The taper is planned from the first consultation and set at the monthly reviews with Dr Quek as the response comes in, rather than written as a fixed schedule on day one.
Dose changes are made at that monthly check-in, and each one is his decision, with the lowest effective dose as the aim. The daily WhatsApp coaching, 9am to 9pm every day, Singapore time, carries on while the dose comes down. Outside those hours an urgent symptom does not wait for a reply: go to an emergency department, or call 995 if it is an emergency. Your own schedule is set by your doctor, for you.
Does the GetLean GLP-1 Taper Plan use microdosing?
Yes. At GetLean, microdosing means taking the medicine below its labelled dose or schedule, and the GetLean GLP-1 Taper Plan gets you there in two ways, and often uses both. With lower doses, you come down to the dose you were on before and stay there until your hunger and cravings are at a level you can handle: someone who reached their goal on Mounjaro 15 mg might come down to 10 mg and stay on 10 mg until they are ready. With longer gaps between injections, instead of one injection every 7 days, you might inject every 8, 9 or 10 days. The two can be combined: for example, going from Mounjaro 15 mg once a week to 10 mg every 10 days.
One safety rule: on higher doses (7.5, 10 or 15 mg), if you go more than 10 days without an injection, the taper restarts on a lower dose. Taking a high dose after a long break can cause stomach and gut side effects, including pancreatitis. Speak to us before your next dose. GLP-1 microdosing at GetLean, step by step sets out each way in full. Every GetLean GLP-1 Taper Plan is set with Dr Quek: book a consultation to plan yours.
Then what does "lowest effective dose" mean?
It is a prescribing principle, and it applies while someone is on treatment rather than only at the end of it.
The principle is that the goal is the smallest dose that achieves the clinical objective, not the largest dose a person can tolerate. What that dose is differs between people, which is why it is a principle rather than a number — and why it is set by the prescribing doctor rather than by a rule.
Two things follow that are worth understanding.
It is a decision for the prescribing doctor, made with the individual in front of them. Dose changes depend on how someone has responded, what side effects they have had, what else they take and what the goal is.
A lower dose is a step on the way down, not a cliff edge. In SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide after 60 weeks were still 16.6% below their starting weight a year later (Horn 2026). At GetLean each step down is made at the monthly check-in with Dr Quek, towards the lowest effective dose.
What happens at GetLean when a patient reaches their goal weight?
Reaching a goal weight on a GLP-1 medication is the point at which the plan built around the medication matters most. The dose comes down to the lowest effective dose, and where clinically appropriate the medication comes off entirely, while the habits built during treatment hold the result. That is the plan the programme is built around from the first consultation, and it is carried out at the monthly reviews with Dr Quek. The goal weight is not a signal to stop on one's own: the dose comes down in steps at the monthly reviews, and each change is his decision.
Goal weight: the weight a patient is working towards. Reaching it is when the plan around the medication — the habits, the planned pace and the planned reduction of the dose — matters most.
How long treatment lasts is set at the monthly reviews; how long to stay on GLP-1 traces the figures people quote on that question to their sources. A plateau, like reaching the goal, is a point to plan the taper with the doctor, not a signal to stop alone.
Already on a GLP-1 with another doctor, and close to your goal?
If you are already on treatment, you are welcome to book your consult. Dr Quek confirms whether the programme is suitable for you at your consultation. What the programme adds around your medication is the rest of the plan: a nutrition and daily activity plan, daily WhatsApp coaching to keep you accountable and build the right habits, and your dose is reviewed regularly with the aim of reaching your lowest effective dose and, where clinically appropriate, a planned exit.
Tell us which GLP-1 medication and dose you are currently taking when you book your consult, and bring any recent records to your consultation. Where it is clinically appropriate, your existing dose can typically be continued rather than restarted. Nothing is prescribed or dispensed before Dr Quek has assessed you, and a consultation does not guarantee that a prescription will be issued. The whole sequence, from booking your consult to the taper, is on one page: switching your Mounjaro treatment to GetLean, step by step.
What can actually be planned
Alongside the taper, the thing to plan is what replaces the medication's effect. In a Copenhagen randomised trial that followed adults for a year after treatment ended, those who had combined a GLP-1 medication with supervised exercise were more likely than those who had taken the medication alone to still hold a loss of at least 10% of their starting weight (Jensen 2024). The medication was liraglutide, an earlier GLP-1 medicine, and the initial loss came from a low-calorie diet.
Resistance training combined with caloric restriction kept lean mass statistically unchanged in the trials that tested that combination (Lopez 2022). Muscle that is still there when the medication stops is muscle that carries on doing its job. Protein intake, an eating pattern that has become ordinary rather than effortful, and training that has become a habit are all things that do not stop when a prescription does.
Holding a loss is something a meaningful minority of people achieve. A 2005 review, from before these medicines, states that roughly 20% of people with overweight lose at least 10% of their starting weight and keep it off for at least a year (Wing and Phelan 2005), and an earlier review noted that once a loss has been held for two to five years, the chance of longer-term success rises substantially (Wing and Hill 2001). Maintaining a loss without medication covers what changes on the day the prescription ends and what carries on.
At GetLean, the programme is designed to end: our philosophy is that GLP-1 medication should act as a catalyst — not something to depend on indefinitely. The exit is worth thinking about from the beginning, because the things that make an exit survivable take months to establish and cannot be assembled in the final few weeks. Designed to end: planning a GLP-1 exit sets out what the plan contains.
In the trials, the weight returned when the medication was taken away, by stopping it or by switching people to placebo. A planned taper changes how the medication comes off, and what someone has built in the meantime is the part that stays under their control.
Individual results vary, and clinical-trial figures describe the populations studied. Never change or stop a prescribed medication on your own — that is a conversation with the doctor who prescribed it.
What happens after the taper at GetLean?
Finishing the taper does not have to end the support. After the taper: daily coaching and a monthly review, no medication: S$88 a month, if you wish. What continuing after the taper includes is set out on the pricing page. If the weight starts coming back, they can come back to Dr Quek at any time: a restart begins with a review consultation, and whether to restart the medication is his decision at that review. Rebound is not failure: restarting, and what cycling does sets out what is known about stopping and restarting.
Designed to end: a programme whose pace and taper off the medication are planned from the first consult, so the result holds after the medication stops.
Read the transcript
How do I taper off Mounjaro or Wegovy? Should you taper off GLP-1, or stop at once?
Step the dose down gradually, with the doctor who prescribed it, never on your own.
I'm Dr Quek, a Singapore-registered doctor, and the doctor behind the GetLean GLP-1 Taper Plan.
Why taper rather than stop at once?
In STEP 4, people were switched from semaglutide, that's Wegovy, to placebo, and their weight rose by six point nine percent on average over the next forty-eight weeks. A planned taper is a different route.
Is there a taper schedule, and how long does it take?
Not one that fits everyone, so I don't publish one. Your steps depend on how you've responded, what side effects you've had, what else you take and what your goal is, and a schedule offered without knowing that would be inventing it. How long it takes is set for each person, not fixed in advance: your own schedule is set by your doctor, for you.
Who decides each step?
Your prescribing doctor, with you in front of them. At GetLean, the taper is planned from the first consultation and set at the monthly reviews as your response comes in, rather than written as a fixed schedule on day one. Daily WhatsApp coaching carries on while the dose comes down.
What does lowest effective dose mean?
It's a principle, not a number: the smallest dose that still reaches your goal, not the biggest you can tolerate. A lower dose is a step on the way down, not a cliff edge. In SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide, that's Mounjaro, were still sixteen point six percent below their starting weight a year later.
What if the weight starts coming back after the taper?
That isn't a failure. At GetLean, you can come back at any time, and a restart begins with a review consultation, where the doctor decides whether to restart the medication.
If you're considering GLP-1 medication to reach your weight goal, and you'd like to taper off it one day, I invite you to visit getleanclinic.sg to learn about our approach and the GetLean GLP-1 Taper Plan.
Common questions
How does GetLean bring the dose down?
Gradually, at Dr Quek's monthly reviews, rather than stopping it overnight, as the STEP 1 extension did. The taper is planned from the first consultation and set as the response comes in, so the schedule is set for each patient. Dose changes are made at the monthly check-in, and each one is his decision.
Why taper rather than stop suddenly?
Because the withdrawal trials took the medication away, by stopping it or by switching people to placebo: in the STEP 1 extension, about two-thirds of the lost weight returned within a year of an overnight stop with no taper (Wilding 2022). At GetLean, we favour a gradual reduction under a doctor's guidance rather than a cliff-edge stop, which allows your appetite to adjust incrementally while the habits built with daily WhatsApp coaching take over. It is a decision to make with your doctor.
What does lowest effective dose mean?
The smallest dose that still achieves the clinical goal, rather than the highest dose a person can tolerate. It is a prescribing principle rather than a number, and the dose that suits one patient will not suit another.
What is a GLP-1 taper designed to do?
Replace an overnight stop with a gradual step-down, so appetite adjusts as the dose falls while the habits built during treatment take over. In the STEP 1 extension, where the medication and the lifestyle support stopped on the same day with no taper, about two-thirds of the lost weight returned within a year (Wilding 2022). A planned taper is designed around that result. Individual results vary.
Can you stay on a lower maintenance dose instead of stopping?
Stepping down to a lower dose is part of how a planned taper works. In SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide after 60 weeks were still 16.6% below their starting weight a year later (Horn 2026). At GetLean the aim is the lowest effective dose, set at Dr Quek's monthly reviews; which dose suits a person, and for how long, is his decision.
How long does it take to come off GLP-1 medication?
It is set for each person rather than fixed in advance. At GetLean the taper is planned from the first consultation and set at Dr Quek's monthly reviews as the response comes in. What matters as much as the pace is what replaces the medication's effect — the eating pattern and the training that carry on afterwards.
What happens when I reach my goal weight on a GLP-1?
That is when the plan you have been building toward matters most. Dr Quek works you down to your lowest effective dose and, where clinically appropriate, off the medication entirely — with the habits you have built holding your results.
Can I stop my GLP-1 on my own once I reach my goal weight?
Never stop or change a prescribed medication on your own; that is a conversation with the doctor who prescribed it. At GetLean we favour a gradual reduction under a doctor's guidance rather than a cliff-edge stop, which allows appetite to adjust incrementally. Each dose change is made at the monthly review with Dr Quek and is his decision.
I am already on a GLP-1 with another doctor and close to my goal weight. Can GetLean help me plan the exit?
You are welcome to book your consult and tell us which GLP-1 medication and dose you are currently taking. Dr Quek confirms whether the programme is suitable for you at your consultation, and your dose is reviewed regularly with the aim of reaching your lowest effective dose and, where clinically appropriate, a planned exit. Nothing is prescribed or dispensed before he has assessed you.
What happens after the taper at GetLean?
A patient can keep the daily WhatsApp coaching and the monthly reviews with Dr Quek by continuing the monthly subscription, if they wish. If the weight starts coming back, they can come back to Dr Quek at any time; a restart begins with a review consultation, and whether to restart the medication is his decision.
Do I need to wean off GLP-1?
It is a decision for the doctor who prescribed it, never one to make on your own, and at GetLean we favour weaning off gradually. Stopping overnight is what the STEP 1 extension did, and about two-thirds of the lost weight returned within a year (Wilding 2022). Under the GetLean GLP-1 Taper Plan, Dr Quek steps the dose down at the monthly reviews instead, towards your lowest effective dose and, where clinically appropriate, off the medication, so appetite adjusts as the dose falls while the habits built during treatment take over. Individual results vary.
Can I take GLP-1 for 3 months and then stop?
None of the withdrawal trials stopped the medication at 3 months: the closest is STEP 4, which switched adults to placebo after a 20-week run-in on semaglutide, and their weight rose by 6.9% on average over the next 48 weeks (Rubino 2021). When to stop is the prescribing doctor's call, made on how you have responded, and never one to make on your own. At GetLean the taper is planned from the first consultation and set at Dr Quek's monthly reviews as the response comes in. Individual results vary.
Does GetLean use microdosing to taper off GLP-1?
Yes. At GetLean, microdosing means taking the medicine below its labelled dose or schedule, and the GetLean GLP-1 Taper Plan gets you there in two ways, and often uses both: lower doses, where you come down to the dose you were on before and stay there until your hunger and cravings are at a level you can handle; and longer gaps between injections, where instead of one injection every 7 days, you might inject every 8, 9 or 10 days. The two can be combined: for example, going from Mounjaro 15 mg once a week to 10 mg every 10 days. On higher doses (7.5, 10 or 15 mg), if you go more than 10 days without an injection, the taper restarts on a lower dose. Taking a high dose after a long break can cause stomach and gut side effects, including pancreatitis. Speak to us before your next dose.